Follow-up on asymptomatic and diagnosed COVID-19 patients in Shanghai
A Follow-up Study of Asymptomatic Infections and Diagnosed Patients With Covid-19 in Shanghai
This study looks at how people with and without symptoms of COVID-19, especially those with the omicron variant, are doing over time in terms of health and well-being.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 250000 (estimated) |
| Sex | All |
| Sponsor | Ruijin Hospital Academic / other |
| Locations | 1 site (Shanghai) |
| Trial ID | NCT05387304 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the distribution characteristics and clinical profiles of asymptomatic infections and diagnosed COVID-19 patients, particularly focusing on the omicron variant. It will assess disease outcomes, risk factors, and changes in multiple organ functions, including cardiopulmonary health, over a long-term follow-up period. Additionally, the study will evaluate social and psychological indicators related to these patients' experiences.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals who have tested positive for SARS-CoV-2 and are willing to provide informed consent.
Not a fit: Patients who do not consent to participate in the study will not benefit from its findings.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term effects of COVID-19, particularly for asymptomatic patients, leading to better management and care strategies.
How similar studies have performed: While there have been various studies on COVID-19, this specific focus on long-term follow-up of asymptomatic infections is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * SARS-Cov-2-RNA positive * informed consent signed Exclusion Criteria: * informed consent rejected
Where this trial is running
Shanghai
- Ruijin Hospital — Shanghai, China (Recruiting)
Study contacts
- Principal investigator: Guang Ning, Ph D — Ruijin Hospital
- Study coordinator: Ying Chen, Ph D
- Email: cy11530@rjh.com.cn
- Phone: +8613917403314
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.